Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis

Qvist Tavs, Pressler Tania, Taylor-Robinson David, Katzenstein Terese L., Høiby Niels

Source: Eur Respir J 2015; 46: 707-716
Journal Issue: September
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Qvist Tavs, Pressler Tania, Taylor-Robinson David, Katzenstein Terese L., Høiby Niels. Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis. Eur Respir J 2015; 46: 707-716

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018


Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018

Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Source: Eur Respir J 2015; 46: 1823-1826
Year: 2015


Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Year: 2020



Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
Source: Eur Respir J 2013; 42: 454-460
Year: 2013



Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005

Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Pneumonectomy in lung infections with Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001

Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy
Source: Eur Respir J, 50 (1) 1602525; 10.1183/13993003.02525-2016
Year: 2017



Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols
Source: Eur Respir J 2016; 48: 1789-1791
Year: 2016


Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009



Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022